-
Innovation Ranking
NewInnovation Ranking – Dana Inc
Dana Inc (Dana) is a manufacturer and distributor of power-conveyance and energy-management systems for automotive and industrial applications. Its major products include front drive axels, Rear drive rigid axles, rear drive units, power transfer units, electromechanical propulsion system, gearboxes, driveshafts, tire inflation systems, electronic controls, torque converters, AWD systems, hydraulic valves, pumps and motors, gaskets, heat shields, sealing systems differentials, and heat transfer products. The company serves light, medium, and heavy vehicle market; construction, agricultural and forestry, mining, and related...
-
Company Insights
Innovation and Patenting activity of Dana Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Dana Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Analyst Opinions
NewNet Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Product Insights
Iron Deficiency Anemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Iron Deficiency Anemia - Drugs In Development, 2023’, provides an overview of the Iron Deficiency Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Iron Deficiency Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Iraq Oil and Gas Exploration and Production Market Volumes and Forecast by Terrain, Assets and Major Companies
Iraq Oil and Gas Exploration and Production Market Report Overview Iraq is the second-largest crude oil producer in the Organization of Petroleum Exporting Countries (OPEC). The country holds a proven oil reserves of 148 billion barrels, making it the fifth-largest holder of crude oil in the world. All of Iraq’s crude oil production comes from onshore fields, with oilfields in the southern province, Al Basrah, which accounts for approximately 70% of the country’s total petroleum production. Most of Iraq’s gas...
-
Product Insights
Chronic Myelomonocytic Leukemia (CMML) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Myelomonocytic Leukemia (CMML) - Drugs In Development, 2023’, provides an overview of the Chronic Myelomonocytic Leukemia (CMML) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Myelomonocytic Leukemia (CMML), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Middle East Respiratory Syndrome (MERS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Middle East Respiratory Syndrome (MERS) - Drugs In Development, 2023’, provides an overview of the Middle East Respiratory Syndrome (MERS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Middle East Respiratory Syndrome (MERS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Lymphocryptovirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Lymphocryptovirus Infections - Drugs In Development, 2023’, provides an overview of the Lymphocryptovirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lymphocryptovirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...